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The data do not support the hypothesis that a carbohydrate-
rich diet per se is associated with unfavorable effects on tri-
aclyglycerols that would be predicted to increase the risk of 
coronary heart disease.  Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 To date, coronary heart disease (CHD) remains the 
leading cause of mortality in high-income countries  [1, 2] 
and the prevalence of type 2 diabetes continues to rise by 
epidemic proportions  [3] . There is considerable epidemi-
ological evidence that these diseases are influenced by 
the life course, and especially by dietary factors  [2, 4, 5] . 
Recently, dietary carbohydrates have received particular 
attention. Depending on their chemical composition and 
physical structure, carbohydrates are digested and ab-
sorbed at different rates and, therefore, have different 
physiological effects, especially on blood glucose and in-
sulin concentrations  [6] . 
 In order to characterize the rate of carbohydrate ab-
sorption after a meal, Jenkins et al.  [7] proposed the con-
cept of the glycemic index (GI) as a physiological basis
for qualitative classification of carbohydrate-containing 
 Key Words 
 Vegan   Glycemic index   Glycemic load   Lipoproteins   
Triacylglycerol   Dietary fiber 
 Abstract 
 Background: To investigate the overall glycemic index (GI), 
glycemic load (GL), and intake of dietary fiber, and to exam-
ine the associations between these factors and plasma lipo-
proteins and triacylglycerols in adult vegans in the German 
Vegan Study (GVS).  Methods: Cross-sectional study, Germa-
ny. Healthy men (n = 67) and women (n = 87), who fulfilled 
the study criteria (vegan diet for  6 1 year prior to study start; 
minimum age of 18 years; no pregnancy/childbirth during 
the last 12 months) and who participated in all study seg-
ments.  Results: The average dietary GL of the GVS popula-
tion was 144, and the average GI was 51.4. The adjusted geo-
metric mean total, HDL, and LDL cholesterol concentrations 
decreased across the increasing quartiles of GL, carbohy-
drate and dietary fiber intake. The associations between to-
tal cholesterol, HDL cholesterol, LDL cholesterol and GL den-
sity and GI were inconsistent. Also, associations between GI, 
GL, the intake of carbohydrates, and triacylglycerol concen-
tration were not observed.  Conclusions: Fiber-rich vegan di-
ets are characterized by a low GI and a low to moderate GL. 
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foods. The GI is defined as the area under the glucose re-
sponse curve (AUC) after consumption of a standard 
amount (50 g) of carbohydrate from a test food, and val-
ues are expressed relative to that of a control food (white 
bread or glucose)  [8, 9] . However, the postprandial blood 
glucose and insulin response depends both on the quan-
tity and quality of carbohydrates, so there is a rationale 
to consider them together. Therefore, the concept of the 
glycemic load (GL) was established by Salmeron et al. 
 [10] . The GL of a selected food is the arithmetic product 
of its GI and its carbohydrate amount  [10] . Several obser-
vational studies have shown that the overall GL and/or 
GI of the diet is/are positively associated with the risk for 
CHD, unfavorable effects on plasma lipoproteins and tri-
acylglycerols  [11–15] and type 2 diabetes  [16–18] . In the 
past, metabolic studies in humans have shown that low-
GI diets improve blood glucose levels, urinary C-peptide 
output  [19] and lipid profiles  [20–23] . These findings 
suggest health benefits of plant-based, high-fiber diets 
with a low GI in the prevention of degenerative diseases 
like CHD and type 2 diabetes mellitus  [4, 6, 24] . There is 
epidemiological evidence that vegetarians are at low risk 
for these life course-related diseases and it is believed that 
this fact is due to the composition of their diet  [25–28] . 
 In general, lacto-(ovo-)vegetarians and vegans con-
sume more minimally processed plant foods like fresh 
fruits, vegetables, whole grain products, legumes and 
nuts  [29, 30] . Therefore it can be hypothesized that such 
diets are characterized by a low GI and thus a low GL. 
Although a large number of studies on vegetarian  [31, 32] 
and vegan nutrition  [30, 33, 34] have been published dur-
ing the last years, only one small study has examined the 
GI of vegan diets  [35] . We therefore investigated the over-
all GI and GL of such diets assessed by a food-frequency 
questionnaire (FFQ). Furthermore, this cross-sectional 
study evaluated the relations of dietary GI and GL as well 
as total fat, carbohydrate and fiber intakes to plasma con-
centrations of lipoproteins and triacylglycerols (TG) in 
154 apparently healthy adult vegans. 
 Methods 
 Ethical Considerations 
 This study was conducted in accordance with the Helsinki 
Declaration of 1964 as amended in 1996. Since there was no in-
tervention, the Ethic Commission of the State of Lower Saxony 
decided that an ethical approval was not required. All subjects 
were volunteers who gave written consent prior to participation 
and who were free to withdraw from the study at any time. 
 Subjects: Recruitment and Screening 
 Participants were recruited by advertisements in eight Ger-
man magazines. In total, 154 persons took part in all study seg-
ments (pre and main questionnaire, FFQ and blood sampling) 
and fulfilled the following study criteria: vegan diet for at least 1 
year prior to the start of the study; a minimum age of 18 years; 
resident in Germany; no pregnancy or childbirth during the last 
12 months. Exclusion criteria were defined as: severe illness dur-
ing the last 12 months (such as malignant or cardiovascular dis-
eases, renal failure, severe diseases of the gastrointestinal tract), 
diagnosed blood coagulation disorder, intake of inhibitors of 
blood coagulation, misuse of alcohol and/or drugs, participation 
in another study during the last month. 
 Life course factors (except alcohol consumption; FFQ) were 
evaluated by means of the study’s main questionnaire, in which 
frequency, duration and kind of physical activity as well as amount 
of smoking (number of cigarettes per day) were assessed. During 
the (physical) examinations the participants were screened for 
health status by a general practitioner (standardized question-
naire with questions regarding (severe) diseases and (minor) 
complications) in order to screen out the existence of any of the 
exclusion criteria. Body height and weight were determined by 
trained personnel. The body weight of participants was measured 
without shoes and with light clothes using a calibrated SECA scale 
and recorded to the nearest 0.1 kg; their body height without shoes 
was determined with a tape measure and recorded to the nearest 
centimeter. BMI was calculated from weight (kg) divided by 
height squared (m 2 ) of each subject. 
 Definition of ‘Vegan’ 
 As previously described, participants were classified as vegan 
when adhering to either a strict vegan diet (SV, n = 98) or a mod-
erate vegan diet (MV, n = 56). The latter was considered a vegan 
diet when a maximum of 5% of the ingested energy from eggs, 
milk and/or dairy products was included  [30] . On the one hand, 
the ingested amounts of eggs (0.88  8 3.31 g/day), milk and dairy 
products (7.95  8 10.1 g/day) in the moderate vegan subgroup was 
so low that it seemed not to be appropriate to name them restrict-
ed lacto-ovo-vegetarians. On the other hand, although all persons 
reported to be vegans, some persons included food of animal ori-
gin in their diet. Moreover, the consumption of eggs, milk and 
dairy products makes it difficult – if not impossible at all – to 
name those persons (strict) vegans. Therefore, we decided to 
name them moderate vegans rather than restricted lacto-ovo-
vegetarians or strict vegans. 
 Dietary Data Collection 
 A slight modification of the validated FFQ used in the Giessen 
Raw-Food Study  [36] was used in the German Vegan Study (GVS) 
for data collection. The original FFQ was complemented for veg-
an foods; foods of animal origin – except eggs, butter, milk and 
dairy products – were excluded. The GVS-FFQ included 199 veg-
an foods and 7 non-vegan foods such as diary products and eggs. 
In the GVS-FFQ, common household measures and their equiva-
lents in grams or milliliters were given for each food item. In some 
cases, portion sizes were made clear with photos or specific com-
ments (i.e. nine strawberries with a size of walnuts weigh 150 g; 
an orange of the size of a tennis ball equals 250 g). In addition, 
participants were asked for copies of recipes of homemade vegan 
dishes. 
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 Each study participant was asked to complete two estimated 
9-day FFQs. In order to minimize seasonal differences, one FFQ 
was completed in autumn, the other one in spring. As there was 
no adequate software or database for vegan nutrition to calculate 
the amounts of ingested nutrients, we developed a piece of soft-
ware (Paradox database) on the basis of the German nutrient da-
tabase (BLS II.2). Missing nutritional information of vegan foods 
and dishes were obtained from the food manufacturers. In the 
end, 245 foods (incl. 18 beverages) were listed in the database. 
 Computing the Dietary GI and GL 
 For the present analysis, most values of GI (GI = 100 corre-
sponding to glucose) and GL of the foods were taken from the 
‘International Table of Glycemic Index and Load’ by Foster-Pow-
ell et al.  [37] . GIs for some foods, for which no published data were 
available, were estimated using the mean of published indexes 
from other, similar foods as suggested by Buyken et al.  [38] . In 
these cases, the GL of each food was computed by multiplying the 
food’s GI and the carbohydrate content of one serving. The over-
all dietary GL for each participant was calculated by multiplying 
the GL per serving of food by the frequency of consumption and 
summed these products over all food items to produce the dietary 
GL. Therefore the formula for the calculation of overall GL is as 
follows  [14] : 
 
 
=
= × ×
1
  
n
i i i
I
Overall dietary GL GI CHO FPD                     (1) 
 where GI i  is the GI for food  i , CHO i  is the carbohydrate content 
in food; (in grams per serving), and FDP i  is the frequency of serv-
ings of food  i  per day. 
 The GL density was computed by dividing the dietary GL by 
energy intake. Additionally, the average GI of the individual’s 
diet, an indicator of the overall quality of carbohydrate intake, 
was determined. According to Liu et al.  [14] the formula for com-
puting the overall dietary GI is the following: 
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 Evaluation of Lipid Parameters 
 Fasting venous blood samples were taken for the measurement 
of lipid parameters. TG concentrations were measured using an  
 enzymatic colorimetric test (GPO-PAP; Boehringer, Germany). 
Total cholesterol was assessed also by an enzymatic colorimetric 
test (CHOD-PAP; Boehringer), while LDL concentrations were 
measured by precipitation with polyvinylsulfate (Boehringer) 
and HDL cholesterol by precipitation with phosphotungstic acid 
(Boehringer). 
 Statistical Methods 
 A statistical analysis program (SPSS 12.0; Chicago, Ill., USA) 
was used to analyze the data. The results are shown as mean  8 
SD and median plus 5th/95th percentiles, respectively. The fol-
lowing two-tailed tests at the 5% level of significance were em-
ployed to evaluate the data: in case of skewness the Mann-Whit-
ney U test was used to evaluate differences between the two sub-
groups (SV and MV). Given normal distribution, the independent 
sample t test was taken. Normal distribution of data was checked 
visually and by using the Kolmogorov-Smirnov test. Dealing with 
nominal data, the   2  test was employed to evaluate statistically 
significant differences. For the subgroups characterized by the 
quartiles of average dietary GL, GL density, average dietary GI as 
well as intake of carbohydrate and dietary fiber, the Kruskal-Wal-
lis test was carried out to reveal statistically significant differ-
ences regarding the demographic, life course, and biochemical 
factors. Using multiple linear regressions the plasma concentra-
tions of TG, total cholesterol, HDL and LDL cholesterol were ad-
justed for potential confounding factors including age, BMI, ciga-
rette smoking, alcohol intake, physical activity, intakes of energy, 
dietary fiber, protein, saturated, monounsaturated, and polyun-
saturated fatty acids. The adjusted geometric means were calcu-
lated by first regressing the natural logarithm of plasma concen-
trations on dietary variables and by exponentiation of the result-
ing mean concentrations. 
 Because of the low variability in BMI (5th percentile: 17.5
kg/m 2 , 95th percentile: 25.4 kg/m 2 ), analyses were not repeated 
with subjects stratified by BMI classes. 
 Results 
 Of the recruited subjects, 56.5% were females (SV 
51.0%, MV 66.1%, p = 0.07,   2 ). Furthermore, the two 
subgroups did not differ in their mean BMI and their 
mean age. Participants reported a total carbohydrate in-
take of 274  8 90.3 g/day, which contributed 57.1  8 7.48% 
to dietary energy. Computed dietary fiber intake was 56.7 
 8 7.74 g/day. The average dietary GL was 144  8 47.3, the 
mean GL density was 17.7  8 3.06 and the average dietary 
GI was 51.4  8 4.25.  Table 1 shows the corresponding data 
for the dietary subgroups SV and MV. Strict vegans had 
significantly higher dietary intakes of polyunsaturat -
 ed fatty acids (PUFA) and  n –6 fatty acids respective -
 ly, whereas the intake of cholesterol was significantly
lower. 
 Dietary GI and GL 
 Table 2 shows to which extent different food groups 
contributed to the overall dietary GL. In the total study 
population, whole grain products and fruits were the 
main contributors to the GL with a median contribution 
of 37.8 and 26.3%, respectively. There were no significant 
differences in age, exercise time, smoking status, and al-
cohol among the dietary quartiles of GI (neither when the 
crude GI was used nor when controlling for energy). But 
among the dietary GLD quartile groups, age distribution 
was significantly different. In the lowest GLD quartile, 
persons were older (47.8  8 15.1 years) than in the highest 
quartile (40.6  8 16.1, p = 0.018). 
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 Lipid Profile 
 The unadjusted mean fasting TG concentration of the 
participants was 0.96  8 0.72 mmol/l (SV 0.96  8 0.80 
mmol/l, MV 0.95  8 0.55 mmol/l; p = 0.724). The unad-
justed mean plasma total cholesterol concentration was 
4.50  8 1.08 mmol/l (SV 4.36  8 0.97 mmol/l, MV 4.75 
 8 1.22 mmol/l; p = 0.044). The unadjusted mean plasma 
HDL cholesterol concentration was 1.34  8 0.34 mmol/l 
(SV 1.30  8 0.33 mmol/l, MV 1.41  8 0.34 mmol/l; p = 
0.070). The unadjusted mean plasma LDL cholesterol 
concentration was 2.63  8 0.98 mmol/l (SV 2.53  8 0.90 
mmol/l, MV 2.81  8 1.09 mmol/l; p = 0.108). The unad-
justed ratio of total cholesterol to HDL was 3.49  8 0.97 
(SV 3.49  8 1.02, MV 3.48  8 0.89; p = 0.956). An asso-
ciation between the intake of saturated fatty acids and the 
unadjusted concentrations of total, HDL, and LDL cho-
lesterol was found (Spearman correlation coefficient each 
r  ! 0.3, p  ! 0.5). Therefore, the multivariate models
were – besides other factors – adjusted for the intake of 
saturated, monounsaturated, and polyunsaturated fatty 
acid intake. 
Strict
vegans, n = 98
Moderate
vegans, n = 56
p
Age, years 43.4815.4 45.7814.2 0.3582
BMI, kg/m2 21.382.73 21.382.20 0.8612
Energy intake, MJ/day 8.5982.97 7.6082.28 0.0332
Carbohydrates, % of energy 56.487.74 58.686.94 0.1462
Protein, % of energy 11.982.11 11.081.90 0.0132
Fat, % of energy 30.388.22 28.887.02 0.2552
Saturated fatty acids, % of energy 5.9181.66 6.1681.84 0.3772
Monounsaturated fatty acids, % of energy 12.585.50 12.384.79 0.8171
Polyunsaturated fatty acids, % of energy 9.0683.48 7.8482.78 0.0262
n–6 fatty acids, g/day 19.2810.4 14.487.24 0.0031
n–3 fatty acids, g/day 1.9881.16 1.9481.13 0.7911
Cholesterol, mg/day 18.0828.2 27.8823.7 <0.0011
Fiber, g/day 58.6822.2 53.5814.9 0.1252
Alcohol consumption, g/day 0.6683.15 0.9783.13 0.0841
Average glycemic index 51.584.51 51.283.81 0.7312
Average glycemic load 148850.1 136841.4 0.1352
Glycemic load density/per MJ energy intake 17.683.27 18.082.66 0.3372
1 Mann-Whitney U test.
2 t test for unpaired samples.
 
 Table 1. Age, BMI, and dietary intakes 
(total energy intake, relation of
macronutrients, fatty acid, fiber and
alcohol intake) and dietary GL, GL
density and average glycemic index of 
strict and moderate vegans within the 
GVS (mean  8 SD) 
Food group Strict vegans
n = 98
Moderate vegans
n = 56
p
Whole grain products 43.0 (1.12/61.5) 33.2 (2.32/62.2) 0.0231
Refined carbohydrates 4.81 (0/23.8) 7.72 (0.06/26.6) 0.1832
Fruits 23.8 (7.56/73.7) 33.0 (8.29/76.2) 0.0222
Vegetables 12.5 (4.50/25.7) 13.6 (3.40/34.9) 0.3241
Juices 1.48 (0/10.4) 1.30 (0/16.7) 0.9242
Legumes, soy 2.09 (0/8.48) 0.76 (0/7.42) 0.0012
Nuts & seeds 0.48 (0/2.46) 0.38 (0.01/3.34) 0.4712
Miscellaneous 2.09 (0/16.1) 2.90 (0/12.8) 0.7212
1 t test for unpaired samples.
2 Mann-Whitney U test.
 
 Table 2. Percentage contribution
of different food groups to the GL within 
the GVS (median plus 5th/95th 
percentiles) 
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 The calculated geometric mean concentrations of TG, 
total cholesterol, HDL, LDL cholesterol and the ratio of 
TC to HDL by quartiles of dietary GL, GL density, aver-
age dietary GI, carbohydrate and dietary fiber intake are 
shown in  table 3 . 
 The adjusted geometric mean plasma concentrations 
of total cholesterol, HDL, and LDL cholesterol decreased 
across the quartiles of dietary GL, carbohydrate and di-
etary fiber intake. While the associations with GL den-
sity and average GI, respectively, were inconsistent. For 
the lowest and the highest quartiles of GL the multivari-
ate-adjusted geometric mean total cholesterol concentra-
tions were 4.92 and 3.97 mmol/l, whereas the geometric 
mean HDL cholesterol concentrations were 1.44 and 1.15 
mmol/l and the geometric mean LDL cholesterol concen-
trations were 2.87 and 2.18 mmol/l, respectively. For the 
 Table 3. Geometric mean plasma concentrations of TG, total cholesterol, HDL and LDL cholesterol across the 
quartiles of dietary GL, GL density and average GI in apparently healthy participants of the GVS 1 
Triacylglycerol
mmol/l
Total cholesterol
mmol/l
HDL cholesterol
mmol/l
LDL cholesterol
mmol/l
TC:HDL ratio
Quartile of GL3
Q1 [87.9] 0.83 (–1.19/2.85) 4.92 (2.92/6.92) 1.44 (–0.55/3.43) 2.87 (0.83/4.90) 3.42 (1.41/5.42)
Q2 [129] 0.81 (–1.21/2.82) 4.39 (2.39/6.40) 1.34 (–0.66/3.34) 2.45 (0.42/4.48) 3.17 (1.29/5.28)
Q3 [154] 0.84 (–1.18/2.85) 4.29 (2.29/6.30) 1.28 (–0.71/3.27) 2.39 (0.36/4.43) 3.35 (1.35/5.35)
Q4 [206] 0.88 (–1.13/2.89) 3.97 (1.96/5.97) 1.15 (–0.84/3.14) 2.18 (0.15/4.22) 3.43 (1.43/5.42)
p2 0.199 <0.001 <0.001 <0.001 0.363
Quartile of GL density3, 4
Q1 [13.9] 0.79 (–1.23/2.80) 4.42 (2.41/6.42) 1.35 (–0.65/3.36) 2.50 (0.47/4.53) 3.27 (1.27/5.27)
Q2 [16.8] 0.85 (–1.16/2.85) 4.39 (2.37/6.40) 1.29 (–0.71/3.29) 2.52 (0.47/4.57) 3.39 (1.39/5.38)
Q3 [18.6] 0.83 (–1.19/2.86) 4.39 (2.38/6.40) 1.30 (–0.70/3.30) 2.47 (0.43/4.51) 3.38 (1.37/5.38)
Q4 [21.7] 0.88 (–1.13/2.89) 4.33 (2.32/6.33) 1.25 (–0.75/3.26) 2.35 (0.31/4.39) 3.44 (1.45/5.43)
p2 0.100 0.849 0.269 0.491 0.438
Quartile of average GI3
Q1 [46.3] 0.82 (–1.20/2.83) 4.43 (2.42/6.45) 1.32 (–0.69/3.33) 2.46 (0.41/4.51) 3.36 (1.36/5.35)
Q2 [49.8] 0.81 (–1.21/2.82) 4.32 (2.31/6.32) 1.31 (–1.11/3.73) 2.41 (0.37/4.44) 3.29 (1.29/5.29)
Q3 [52.5] 0.85 (–1.69/3.38) 4.34 (2.35/6.36) 1.29 (–0.70/3.29) 2.45 (0.41/4.48) 3.36 (1.36/5.35)
Q4 [56.9] 0.88 (–1.14/2.90) 4.42 (2.41/6.44) 1.27 (–0.73/3.27) 2.52 (0.47/4.58) 3.48 (1.47/5.48)
p2 0.132 0.793 0.738 0.904 0.227
Quartile of carbohydrate intake3
Q1 [172] 0.83 (–1.19/2.85) 4.93 (2.93/6.93) 1.44 (–0.54/3.42) 2.90 (0.87/4.93) 3.42 (1.42/5.42)
Q2 [239] 0.80 (–1.21/2.82) 4.44 (2.44/6.45) 1.36 (–0.64/3.35) 2.48 (0.45/4.51) 3.29 (1.29/5.28)
Q3 [289] 0.84 (–1.18/2.86) 4.23 (2.22/6.23) 1.26 (–0.74/3.26) 2.34 (0.30/4.37) 3.34 (1.34/5.34)
Q4 [394] 0.88 (–1.13/2.88) 3.97 (1.97/5.97) 1.15 (–0.84/3.15) 2.18 (0.14/4.22) 3.43 (1.43/5.42)
p2 0.120 <0.001 <0.001 <0.001 0.314
Quartile of dietary fiber intake3
Q1 [36.4] 0.87 (–1.14/2.89) 4.88 (2.88/6.88) 1.41 (–0.59/3.40) 2.85 (0.82/4.89) 3.47 (1.47/5.47)
Q2 [48.6] 0.81 (–1.21/2.83) 4.57 (2.57/6.57) 1.38 (–0.62/3.38) 2.59 (0.56/4.62) 3.31 (1.31/5.31)
Q3 [61.7] 0.82 (–1.19/2.84) 4.13 (2.13/6.14) 1.25 (–0.74/3.25) 2.27 (0.24/4.29) 3.29 (1.30/5.29)
Q4 [80.7] 0.84 (–1.17/2.86) 3.99 (1.99/5.99) 1.17 (–0.83/3.16) 2.19 (0.14/4.23) 3.41 (1.41/5.41)
p2 0.235 <0.001 <0.001 <0.001 0.154
1 95% CI in parentheses. All models were adjusted simultaneously for age (5-year categories), BMI (4 catego-
ries), cigarette smoking (yes/no), alcohol intake (3 categories), physical activity (3 categories), energy intake, 
saturated fat, monounsaturated and polyunsaturated fatty acid, protein, energy, and dietary fiber intake (each 
in quartiles).
2 Kruskal-Wallis H-test.
3 Mean value for each quartile in brackets.
4 GL density was computed by dividing the dietary GL load by energy intake.
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lowest and the highest quartiles of carbohydrate intake 
the multivariate-adjusted geometric mean total choles-
terol concentrations were 4.93 and 3.97 mmol/l, whereas 
the geometric mean HDL cholesterol concentrations were 
1.44 and 1.15 mmol/l and the geometric mean LDL cho-
lesterol concentrations were 2.90 and 2.18 mmol/l, re-
spectively. For the lowest and the highest quartiles of di-
etary fiber intake the multivariate-adjusted geometric 
mean total cholesterol concentrations were 4.88 and 3.99 
mmol/l, whereas the geometric mean HDL cholesterol 
concentrations were 1.41 and 1.17 mmol/l and the geo-
metric mean LDL cholesterol concentrations were 2.85 
and 2.19 mmol/l, respectively. 
 However, statistically significant associations or trends 
were not observed for GI, GL, the intake of carbohydrates, 
and plasma TG concentrations. 
 Discussion 
 In the present study conducted with adult vegans from 
Germany it was assumed that a vegan diet is character-
ized by a low GI and GL. The average dietary GI of the 
GVS study population was 51. Compared to the results of 
several observational studies  [10–18] , the overall GI of the 
vegan diet seems to be low and, therefore, may be one fac-
tor to explain the lower risk for CHD and type 2 diabetes 
of vegan subjects in comparison to omnivores  [25] . How-
ever, it is difficult to accurately compare the mean GIs in 
the different studies, because different GI values (glu-
cose- or white bread-based) are used. While we have tak-
en glucose-based values, eight of the observational stud-
ies cited above  [10–18] either did not indicate which one 
they used or stated they used white bread-based values. 
Only the study of Amano et al.  [15] used glucose-based 
values as we did in our study. When taking the conversion 
factor of approximately   0.7 into account to convert 
white bread- into glucose-based GI values  [37] , the aver-
age GI of the GVS study falls within the lowest GI quintile 
of the most observational studies. For example, in the 
Nurses’ Health Study (NHS) with 65,173 participants, the 
lowest GI quintile was 64 and this was associated with the 
lowest risk for diabetes mellitus type 2  [10] . Similar re-
sults were observed in a cohort study with 42,759 men, 
who were 40–75 years old. In this study, the dietary GI of 
the lowest quintile was 65  [16] . After adjustment for age, 
BMI, smoking, physical activity, family history of diabe-
tes, alcohol consumption, cereal fiber, and total energy 
intake, the relative risk for diabetes mellitus type 2 was 
37% lower in the lowest GI quintile compared with the 
highest quintile of GI  [16] . The cohort study of Schulze et 
al.  [18] supports our assumption that the GI of a vegan 
diet is rather low. In this large study with 91,249 women 
the lowest GI quintile was 70. This quintile was associ-
ated with a 60% lower multivariate relative risk for diabe-
tes mellitus type 2. In addition in the cohort study by Liu 
et al.  [12] , using data from 10 years of follow-up on 75,000 
women, the GI of the lowest quintile was 72. 
 The average dietary GL of the GVS cohort was 144. In 
comparison to the findings from observational studies 
with omnivores  [12, 14, 15, 39] the reported GL with the 
vegan diet was low to moderate. For example, in the total 
cohort of the NHS the mean value for the lowest and 
highest quintile of GL was 117 and 206, respectively. In 
this study the GL and the risk of CHD were positively as-
sociated – even after multiple adjustments were made 
 [12] . 
 Since there are associations between higher dietary GI 
or GL and risk for CHD disease  [11–15, 39, 40] the rela-
tions of dietary GI and GL to plasma concentrations of 
lipoproteins such as total cholesterol, HDL, LDL choles-
terol, the ratio of TC:HDL, and TG were examined. Con-
trary to the results of several observational studies  [11, 14, 
15, 40] , there were no significant associations between 
TG, total cholesterol, HDL, LDL, TC:HDL, and the aver-
age GI in the GVS study population. This observation 
may be explained by the fact that there is only a small dif-
ference between the lowest (Q1: 46) and highest (Q4: 57) 
quartile of dietary GI in our vegan study population. 
Therefore, all quartiles are characterized by a low GI 
when compared to the studies of Frost et al.  [11] , Liu et al. 
 [14] , and Amano et al.  [15] . For this reason, the GVS re-
sults are not surprising, since all vegan subjects con-
sumed a low-GI diet. In this context a recent meta-analy-
sis is of interest. In this analysis of 14 randomized con-
trolled trials of low-GI versus high-GI diets, low-GI diets 
caused a statistically significant improvement in total 
cholesterol concentrations, while there were no signifi-
cant effects on LDL, HDL cholesterol and TG  [41] . This 
indicates that the influence of the overall dietary GI on 
markers of lipid metabolism still remains controversial. 
 In our study the adjusted geometric mean plasma con-
centrations of cholesterol, HDL and LDL cholesterol de-
creased across the quartiles of dietary GL while there was 
no significant correlation between GL and TG. Except for 
HDL cholesterol, this result is in contrast to the findings 
of other investigators  [13–15, 40] . For example, in the 
NHS cohort of Liu et al.  [14] a significant rise of TG was 
observed with increasing GL. Furthermore, GL remained 
a significant predictor of fasting TG concentrations. Be-
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cause GL is defined as the product of GI and carbohydrate 
content  [10, 16] ,  carbohydrate intake of the GVS cohort is 
of interest. With a mean intake of 274 g/day (57.1 energy 
%) the diet of the subjects in our study is comparatively 
high in carbohydrates. In observational studies like the 
postmenopausal female subcohort of the NHS, ascending 
quintiles of carbohydrate intake were associated with in-
creasing TG concentrations  [14] . In addition, total carbo-
hydrate intake was inversely associated with HDL choles-
terol concentrations  [40] . 
 Data from metabolic studies support the observation 
that high-carbohydrate diets increase TG or reduce HDL 
cholesterol and therefore could translate into a higher 
risk of CHD  [42, 43] . However, our results and those of 
Goff et al.  [35] show that vegan diets rich in carbohy-
drates are not or only partially associated with such neg-
ative effects on the lipid profile. Other studies have shown 
that the HDL cholesterol reduction and rise of TG seen 
with some high-carbohydrate diets may be short-term ef-
fects  [44, 45] and depends mainly on the carbohydrate 
quality of such diets. For example, Harbis et al.  [46] stud-
ied two mixed meals that were reasonably matched for 
macronutrient composition but differed in their content 
of slowly available glucose (flake-based versus biscuit-
based meal). The plasma TG and the apolipoprotein B-
100 and B-48 concentration increased significantly after 
the flakes meal (high GI) but not after the biscuit meal 
(low GI) in obese, insulin-resistant subjects. Similar re-
sults were observed in healthy individuals with different 
GI meals  [47] . A recently published randomized trial of 
overweight or obese adults with dyslipidemia or fasting 
hyperglycemia shows no significant undesirable effects 
of a high-carbohydrate, low-GI diet (Ornish) on TG and 
HDL cholesterol when compared with a low-carbohy-
drate diet (Atkins)  [48] . Furthermore, a reduction in the 
overall dietary GI by at least 12 units reduces the TG con-
centration by approximately 9% in 10 of 11 long-term 
studies lasting from 1 week to 3 months  [49] . Other in-
vestigators have shown that a high-carbohydrate, but 
low-GI diet significantly increased HDL cholesterol con-
centrations compared to an isocaloric high-carbohydrate 
diet with a high GI  [50] . 
 The exact mechanisms related to lipid modulation by 
low-GI diets still remain poorly understood. It is known 
that the glycemic and insulinemic response after con-
sumption of a low-GI meal is relatively slow compared to 
a high-GI meal  [51–53] . The resulting comparatively low 
insulin concentration after a low-GI meal may reduce the 
insulin-stimulated HMG-CoA reductase activity and 
thus may reduce cholesterol synthesis  [24] . Another pos-
sible mechanism is that the low insulin response could 
modulate VLDL synthesis in a favorable way  [46] . 
 Because the low-GI vegan diet of our subjects was 
based on minimally processed plant foods like fresh 
fruits, vegetables, whole grain products, legumes, and 
nuts  [30] , the low GI observed in this study is only one 
aspect of such a carbohydrate-rich diet. Concerning the 
risk factors of CHD such as plasma lipids (LDL, HDL 
cholesterol), another important aspect is the high fiber 
intake (56.7 g/day) observed in our study. In the GVS 
study population the adjusted geometric mean plasma 
concentrations of total cholesterol, HDL and LDL choles-
terol decreased across the quartiles of dietary fiber in-
take. Except for HDL cholesterol, these findings are con-
sistent with the results of several observational as well as 
clinical studies which have shown favorable effects of fi-
ber-rich diets on the lipid profile. Especially soluble fiber 
abundant in fruits, legumes, and oat cereals exhibit LDL 
cholesterol-lowering properties and reduce TG levels 
 [54] . A meta-analysis from 10 prospective cohort studies 
supported the CHD protective effect of a fiber-rich vegan 
diet. In this analysis dietary fiber from cereals and fruits 
was inversely associated with the risk of CHD  [55] . Of 
course, there are a lot of other bioactive components in a 
vegan diet that alter plasma lipoproteins and TG. For ex-
ample, phytosterols, monounsaturated fatty acids and 
vegetable protein in nuts have LDL cholesterol-lowering 
effects  [56, 57] . 
 Furthermore, the vegan diet in our study collective 
was characterized by a low intake of saturated fatty acids 
(6.0  8 1.7 energy %) and dietary cholesterol (21.5  8 27.0 
mg/day), which may have a favorable impact on lipid pro-
file. The multivariate analysis of the data allowed for con-
sidering some of these confounders by including them in 
the analysis. 
 Taking our data together with a series of clinical stud-
ies conducted from the Jenkins group  [58–60] and the 
Ornish group  [61–64] with high-fiber, carbohydrate-rich 
and low-GI diets, our results support the assumption that 
carbohydrate quality, not quantity is primarily important 
for lipid markers and CHD risk reduction. From the 
background of the current low-carbohydrate debate, our 
results, therefore, may be of interest for public health. 
 The most important limitation that should be men-
tioned when examining the results of this study is the use 
of a FFQ, which was not specifically designed to assess GI 
and GL. But this limitation occurs in some other studies 
as well  [18] . Furthermore, the overall accuracy of the 
measurement of food intake via FFQ in general  [65] and 
particularly the validity in view of measures the GI and 
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GL of the diet  [66] have been questioned. Because FFQs 
have substantial limitations  [67] , the above-mentioned 
questions arise also when interpreting the results of this 
study. However, up to now, the FFQ is the standard tool 
for dietary assessment in all large epidemiological studies 
and the results of those studies are still relevant  [68, 69] . 
Another limitation is the measurement of surrogate 
markers (i.e. lipid parameters) instead of CHD endpoints 
such as CHD-related mortality or cardiac events. Also 
the relatively small number of vegan persons in this study 
might weaken the power of our results. To our knowl-
edge, publications from the British EPIC cohort (e.g. Dav-
ey et al.  [70] ) are the first data source with a vegan sample 
size of more than 250 persons, while other studies on
vegetarian and vegan cohorts have smaller sample sizes 
too – not at least due to the small number of vegans found 
in a population. 
 Conclusion 
 A vegan diet including large amounts of fruit, vegeta-
bles, whole grains, legumes, and nuts is characterized by 
a low GI and GL. Especially the latter is associated with 
decreased total and LDL cholesterol plasma concentra-
tions which are expected to be cardioprotective in the 
long run. Overall, these data do not support the hypoth-
esis that a carbohydrate-rich diet per se is associated with 
unfavorable effects on TG that would be predicted to in-
crease the risk of CHD. 
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